Copyright © Inderes 2011 - present. All rights reserved.
  • Seneste
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Udbyttekalender
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team
Pressemeddelelse

Enzymatica AB: Invitation to Press Briefing - 5 March 2025

Enzymatica

In connection with the publication of results from two independent research studies on ColdZyme, Enzymatica AB invites to a digital press briefing on 5 March 2025.

  • 13:00-14:10 The researchers will present their findings and be available for questions
  • 14:15-15:00 Enzymatica's CEO, Claus Egstrand, and Chairman, Bengt Baron, will present a company overview and be available for questions

The press briefing will be broadcast live. To participate in the live discussion, please register via this link: https://creo-live.creomediamanager.com/eda7c0f6-7107-4d87-b409-82bdf2d58605

Read the press release published on 28 February here:
https://www.enzymatica.com/media/press-releases/2025/new-independent-studies-show-that-coldzyme-addresses-the-root-cause-of-respiratory-infections-reducing-sick-days-and-symptoms/

Link to the published article in The Journal of Physiology:
https://physoc.onlinelibrary.wiley.com/doi/10.1113/JP288136

 

Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.